BioNexus Gene Lab Corp. Operating Lease Liability
BioNexus Gene Lab Corp. (BGLC) had Operating Lease Liability of $146.03 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-14
- 2026-06-30: Operating Lease, Liability $146.03K.
- 2026-03-31: Operating Lease, Liability $162.05K.
- 2025-12-31: Operating Lease, Liability $176.05K.
- 2025-09-30: Operating Lease, Liability $183.75K.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $146.03K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $162.05K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $176.05K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $183.75K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $197.16K 10-Q · filed 2025-08-18 |
| 2025-03-31 | $200.11K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $210.56K 10-K · filed 2026-04-14 |
| 2024-09-30 | $25.34K 10-Q · filed 2024-11-15 |
| 2023-12-31 | $133.40K 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |